The Lupus Research Alliance has awarded its 2023 Lupus Insight Prize to a researcher for her pioneering discovery that…
Lindsey Shapiro
Lindsey earned her PhD in neuroscience from Emory University in Atlanta, where she studied novel therapeutic strategies for treatment-resistant forms of epilepsy. She was awarded a fellowship from the American Epilepsy Society in 2019 for this research. Lindsey also previously worked as a postdoctoral researcher, studying the role of inflammation in epilepsy and Alzheimer’s disease.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Lindsey Shapiro
Lupkynis (voclosporin) combined with background lupus treatments better preserved kidney function among a subgroup of lupus nephritis patients…
A year of treatment with upadacitinib led to significant disease activity reductions for people with systemic lupus erythematosus (SLE),…
KYV-101, an investigational cell therapy from Kyverna Therapeutics, has been granted a fast track designation by the U.S. Food…
JW Therapeutics has received approval from Chinese authorities to open a clinical trial of its CAR T-cell therapy,…
The U.S. Food and Drug Administration (FDA) has cleared a Phase 1/2 clinical trial to test CABA-201, Cabaletta Bio’s…
Blood levels of an immune system protein called sBCMA were found elevated in untreated children with systemic lupus erythematosus…
A failure of tingible body macrophages (TBMs), a type of immune cell tasked with cleaning up its environment, might play…
Black people with systemic lupus erythematosus (SLE) are at a higher risk of developing heart disease — especially in…
Low blood levels of hydroxychloroquine (HCQ) put people with systemic lupus erythematosus (SLE) at higher risk of experiencing disease exacerbations,…